Zepbound Cost 2026: Monthly Pricing Breakdown
Zepbound cost breakdown for 2026: monthly pricing without insurance, dose-by-dose expenses, savings options, and how compounded tirzepatide costs 90% less.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Pricing data reflects current market information and is updated when significant changes occur.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Zepbound Pricing in 2026
Zepbound, Eli Lilly's tirzepatide product approved specifically for chronic weight management, entered the market in late 2023 as the first tirzepatide product with an FDA weight loss indication. For patients and their doctors, this dedicated approval was significant because it created a clearer pathway for insurance coverage for weight loss treatment. However, the retail pricing tells a familiar story — brand-name GLP-1 medications in the US remain prohibitively expensive for most patients without insurance.
Zepbound's list price in 2026 sits at approximately $1,060 per month without insurance. This price is the same regardless of dose level, from the 2.5mg starting dose through the 15mg maximum dose. Eli Lilly has positioned Zepbound slightly below competitor pricing for Wegovy, though the difference is relatively small in the context of monthly costs exceeding $1,000.
For patients paying out of pocket, the annual cost of Zepbound approaches $12,720 — a number that exceeds what many Americans spend on housing in a year. This pricing reality continues to drive patients toward compounded tirzepatide alternatives that deliver the same active ingredient at dramatically lower cost points.
Dose-by-Dose Cost Comparison
| Dose Level | Zepbound Retail | Compounded Tirzepatide | Monthly Savings |
|---|---|---|---|
| 2.5mg weekly | ~$1,060/mo | ~$125/mo | ~$935/mo |
| 5mg weekly | ~$1,060/mo | ~$125/mo | ~$935/mo |
| 7.5mg weekly | ~$1,060/mo | ~$175/mo | ~$885/mo |
| 10mg weekly | ~$1,060/mo | ~$199/mo | ~$861/mo |
| 12.5mg weekly | ~$1,060/mo | ~$225/mo | ~$835/mo |
| 15mg weekly | ~$1,060/mo | ~$250/mo | ~$810/mo |
At every dose level, compounded tirzepatide through Trimi saves patients $800 or more per month compared to brand-name Zepbound. Over a year, those savings total $9,700 to $11,200 depending on maintenance dose. For patients who need to sustain treatment for 12 to 24 months to achieve and maintain optimal results, the cumulative savings can exceed $20,000.
Pricing Note
Telehealth and pharmacy pricing changes frequently. The figures in this comparison reflect observed pricing in early 2026. Always verify current pricing directly on each provider's website before making a decision.
Insurance Coverage for Zepbound
Zepbound's dedicated FDA approval for weight management gives it a theoretical advantage over Mounjaro for insurance coverage of obesity treatment. However, the practical reality of insurance coverage in 2026 remains inconsistent. While more plans are beginning to cover anti-obesity medications, coverage is far from universal.
Patients who do have insurance coverage for Zepbound should be aware of several potential cost factors beyond the base medication price: prior authorization requirements that can delay treatment by weeks, step therapy mandates requiring trial of other medications first, specialty tier copays that may range from $100 to $500 per month even with coverage, and annual out-of-pocket maximums that reset each year.
For patients whose insurance does not cover Zepbound, or whose coverage leaves them with high out-of-pocket costs, compounded tirzepatide through a provider like Trimi eliminates the insurance complexity entirely. No prior authorization, no formulary battles, no coverage denials — just straightforward monthly pricing that includes everything you need.
Zepbound Savings Programs
Eli Lilly has introduced several savings programs to help patients access Zepbound at lower costs. Understanding what these programs offer — and their limitations — is important for patients evaluating their options.
Savings program limitations:
Most programs require existing commercial insurance coverage as a prerequisite
Medicare, Medicaid, and government insurance participants are typically ineligible
Programs have maximum benefit caps that limit total savings
Eligibility criteria may exclude patients based on plan type or formulary status
Programs have expiration dates and may not be renewed
Enrollment processes can be complex and time-consuming
For patients who qualify for Eli Lilly's savings programs and have supporting insurance coverage, these programs can make Zepbound more affordable. For everyone else — which represents the majority of patients seeking weight loss treatment — compounded tirzepatide through an established telehealth provider remains the most reliable and affordable access pathway. Compare the options in detail with our Zepbound alternatives guide.
Long-Term Cost Projections
GLP-1 weight loss treatment is most effective when sustained over time. Patients who stop treatment often experience weight regain, making long-term affordability a critical factor in treatment planning. The cost difference between Zepbound and compounded tirzepatide becomes even more significant when projected over multi-year treatment courses.
| Treatment Duration | Zepbound Total Cost | Compounded Total Cost | Total Savings |
|---|---|---|---|
| 6 months | ~$6,360 | ~$900 | ~$5,460 |
| 1 year | ~$12,720 | ~$1,800 | ~$10,920 |
| 2 years | ~$25,440 | ~$3,600 | ~$21,840 |
| 3 years | ~$38,160 | ~$5,400 | ~$32,760 |
Over a two-year treatment course, patients choosing compounded tirzepatide over Zepbound save approximately $21,840. Over three years, savings approach $33,000. These are not abstract numbers — they represent real financial resources that patients can direct toward other health investments, family needs, or financial goals rather than pharmaceutical company profits.
Bottom Line
Zepbound is an outstanding medication backed by exceptional clinical data. Its dedicated FDA approval for weight management is a meaningful distinction that may improve insurance coverage prospects for some patients. However, at approximately $1,060 per month without insurance, Zepbound remains unaffordable for the majority of patients seeking weight loss treatment.
Compounded tirzepatide delivers the identical active ingredient at 75 to 90 percent lower cost. Through Trimi, patients access tirzepatide starting at $125 per month with transparent pricing, dedicated weight management support, and no long-term contracts. The medication is the same — the price is what is different. For most patients, that difference makes compounded tirzepatide the clear choice for sustainable, long-term GLP-1 weight loss treatment.
Frequently Asked Questions
How much does Zepbound cost per month in 2026?
Zepbound's retail price without insurance is approximately $1,060 per month in 2026, consistent across all dose levels. Over a full year, that totals approximately $12,720. With insurance coverage (where available), copays vary widely from $25 to $500 per month depending on your plan. Compounded tirzepatide — the same active ingredient — is available through providers like Trimi starting at approximately $125 per month.
Is Zepbound cheaper than Mounjaro?
Zepbound and Mounjaro contain the identical active ingredient (tirzepatide) made by Eli Lilly. Zepbound's list price is approximately $1,060 per month, while Mounjaro is approximately $1,050 per month — essentially the same. The primary difference between the two brands is the FDA-approved indication: Zepbound is approved for weight management while Mounjaro is approved for type 2 diabetes. Insurance coverage may differ between the two based on the approved indication and your specific plan.
Does the Zepbound savings card work?
Eli Lilly offers a savings program for Zepbound that can reduce out-of-pocket costs for eligible patients. The program typically requires commercial insurance coverage and has restrictions on who can participate. Patients on Medicare, Medicaid, or without insurance generally cannot use the savings card. When eligible, patients may pay as little as $25 per month. However, eligibility criteria, benefit caps, and program duration limit the long-term reliability of this savings pathway.
Does Medicare cover Zepbound?
Medicare coverage for Zepbound is evolving. Traditional Medicare Part D plans have historically excluded anti-obesity medications, but policy changes have been expanding coverage. As of 2026, some Medicare plans may cover Zepbound with prior authorization, but coverage is not universal. Patients on Medicare should verify their specific plan's formulary and discuss options with their provider. Compounded tirzepatide at $125 to $250 per month often costs less than Medicare copays for specialty tier medications.
Why is Zepbound so expensive?
Zepbound's price reflects Eli Lilly's enormous investment in developing tirzepatide — including years of clinical trials (the SURMOUNT program), FDA regulatory approval, manufacturing infrastructure, and global marketing. These costs are built into the retail price and protected by patent exclusivity. The US pharmaceutical market allows manufacturers to set prices without government price controls, resulting in prices that are several times higher than in other developed countries. Compounded alternatives bypass these cost structures while delivering the same active ingredient.
What is the cheapest way to get tirzepatide for weight loss?
The most affordable path to tirzepatide in 2026 is through compounded tirzepatide from a reputable telehealth provider. Platforms like Trimi offer compounded tirzepatide starting at $125 per month — approximately 88 percent less than Zepbound's retail price. This includes the medication, provider consultations, medical oversight, and shipping with no hidden fees or long-term contracts. The active ingredient is identical to what is in Zepbound and Mounjaro.
Can I get Zepbound from Canada or overseas for less?
While some patients explore international pharmacies for lower drug prices, importing prescription medications for personal use exists in a legal gray area. The FDA generally does not approve of importing prescription drugs from other countries, and there are quality and safety concerns with overseas pharmacies. Compounded tirzepatide from US-based, accredited compounding pharmacies offers a legal, safe, and more affordable domestic alternative without the risks and complications of international medication sourcing.
Sources & References
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Pricing information reflects publicly available data and may change. Always verify current pricing directly with providers. Trimi offers compounded tirzepatide — readers should be aware of our perspective when evaluating the information presented.